SSDMEDIUM SIGNALFINANCIAL10-K

Simpson Strong-Tie substantially strengthened its balance sheet while reducing R&D spending by nearly half.

The company generated strong operating cash flow growth and meaningfully improved its financial position by reducing debt 23% while building cash reserves. However, the significant reduction in R&D expenses could signal either improved efficiency or potential concern about future innovation investment in this engineering-focused business.

Comparing 2026-02-27 vs 2025-03-03View on EDGAR →
FINANCIAL ANALYSIS

Simpson Strong-Tie demonstrated robust financial performance with operating cash flow growing 36% and cash reserves substantially higher at $384M versus $239M. The company deleveraged meaningfully by reducing total debt from $388M to $300M while growing total assets 12% to $3.1B, indicating strong balance sheet management. The notable decline in R&D expenses from $21M to $12M represents the primary operational change, which could reflect either cost optimization or shifting investment priorities in their structural solutions business.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+60.5%
$239.4M$384.1M

Cash position surged 60.5% — strong cash generation or capital raise providing significant financial cushion.

R&D Expense
P&L
-44.4%
$20.7M$11.5M

R&D spending cut 44.4% — could signal cost discipline or concerning reduction in innovation investment.

Operating Cash Flow
Cash Flow
+35.6%
$338.2M$458.7M

Operating cash flow surged 35.6% — exceptional cash generation, highest quality earnings signal.

Total Debt
Balance Sheet
-22.7%
$388.1M$300.0M

Debt reduced 22.7% — deleveraging strengthens balance sheet and reduces financial risk.

Share Buybacks
Cash Flow
+20%
$100.0M$120.0M

Share repurchases increased 20% — management returning capital, signals confidence in intrinsic value.

Current Assets
Balance Sheet
+15%
$1.2B$1.4B

Current assets grew 15% — improving short-term liquidity or inventory/receivables build.

Total Liabilities
Balance Sheet
+12.5%
$923.0M$1.0B

Liabilities increased 12.5% — monitor debt-to-equity ratio and interest coverage.

Stockholders Equity
Balance Sheet
+12.4%
$1.8B$2.0B

Equity base grew 12.4% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Total Assets
Balance Sheet
+12.3%
$2.7B$3.1B

Asset base grew 12.3% — expansion through organic growth, acquisitions, or capital deployment.

LANGUAGE CHANGES
NEW — 2026-02-27
PRIOR — 2025-03-03
ADDED
See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and emerging growth company in Rule 12b-2 of the Exchange Act.
As of February 23, 2026, 41,402,035 shares of the registrant s common stock were outstanding.
Such Proxy Statement will be filed with the Securities and Exchange Commission (the SEC ) within 120 days of the registrant's fiscal year ended December 31, 2025.
( Simpson, the Company, we, us, or our, ) through its subsidiaries, including, Simpson Strong-Tie Company Inc.
( SST ), designs, engineers and is a leading manufacturer of structural solutions primarily for wood and concrete.
+7 more — sign up free →
REMOVED
See the definitions of large accelerated filer, accelerated filer, smaller reporting company, and "emerging growth company" in Rule 12b-2 of the Exchange Act.
As of February 24, 2025, 41,974,436 shares of the registrant s common stock were outstanding.
Such Proxy Statement will be filed with the Securities and Exchange Commission (the "SEC") within 120 days of the registrant's fiscal year ended December 31, 2024.
("Simpson," the "Company," "we," "us," or "our,") through its subsidiaries, including, Simpson Strong-Tie Company Inc.
("SST"), designs, engineers and is a leading manufacturer of structural solutions for wood, concrete, and steel connections.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →